Literature DB >> 28959105

Relationship between Peripheral Arterial Stiffness and Estimated Pulmonary Pressure by Echocardiography in Systemic Sclerosis.

Burabha Pussadhamma1, Wannipa Suwannakrua1, Panorkwan Toparkngarm1, Chaiyasith Wongvipaporn1, Chingching Foocharoen2, Ratanavadee Nanagara2.   

Abstract

BACKGROUND: Pulmonary hypertension (PH) is an important lethal manifestation of systemic sclerosis (SSc). Evidence of an association between peripheral and pulmonary arterial vasculopathy in SSc has been demonstrated. We hypothesized that peripheral arterial stiffness could predict PH in SSc.
METHODS: We performed a cross-sectional study among patients with SSc who underwent Cardio-Ankle Vascular Index (CAVI, VaSera VS-1000; Fukuda Denshi, Tokyo, Japan) and transthoracic echocardiography (TTE) examination to evaluate peripheral arterial stiffness and PH, respectively. The correlation between CAVI score and PH hemodynamics [right ventricular systolic pressure (RVSP) and tricuspid regurgitation velocity (TRV)] was studied.
RESULTS: A total of 145 patients underwent both CAVI and TTE evaluation. The mean (standard deviation, SD) patient age was 51.5 (12.3) years; female patients constituted 72% of the subjects. Diffuse SSc occurred in 75% of the cases. The mean (SD) CAVI score was 7.6 (0.9), and the mean (SD) RVSP was 29.9 (11.2) mmHg. Correlation coefficient (r) between CAVI score and RVSP in overall, limited, and diffuse SSc were 0.107 (p = 0.200), 0.040 (p = 0.815), and 0.194 (p = 0.043), respectively. CAVI scores were borderline or abnormal (≥ 8) in 30.3% of subjects. PH was classified intermediate or high probability (TRVmax ≥ 2.9 m/s) in 19.3% of the subjects. Among the overall population, the odds ratios (95% CI) of CAVI score ≥ 8 for TRVmax ≥ 2.9 m/s in univariate and multivariate analysis were 1.23 (0.46-3.21, p = 0.678), and 0.54 (0.10-2.84, p = 0.471), respectively.
CONCLUSIONS: Peripheral arterial stiffness, as measured by CAVI, has a correlation trend with the level of pulmonary arterial pressure assessed by TTE, specifically in the diffuse SSc subgroup.

Entities:  

Keywords:  Cardio-Ankle Vascular Index; Peripheral arterial stiffness; Pulmonary hypertension; Systemic sclerosis

Year:  2017        PMID: 28959105      PMCID: PMC5611349          DOI: 10.6515/acs20170220a

Source DB:  PubMed          Journal:  Acta Cardiol Sin        ISSN: 1011-6842            Impact factor:   2.672


  32 in total

Review 1.  Pulmonary arterial hypertension.

Authors:  Harrison W Farber; Joseph Loscalzo
Journal:  N Engl J Med       Date:  2004-10-14       Impact factor: 91.245

Review 2.  Recommendations for the evaluation of left ventricular diastolic function by echocardiography.

Authors:  Sherif F Nagueh; Christopher P Appleton; Thierry C Gillebert; Paolo N Marino; Jae K Oh; Otto A Smiseth; Alan D Waggoner; Frank A Flachskampf; Patricia A Pellikka; Arturo Evangelista
Journal:  J Am Soc Echocardiogr       Date:  2009-02       Impact factor: 5.251

3.  A novel blood pressure-independent arterial wall stiffness parameter; cardio-ankle vascular index (CAVI).

Authors:  Kohji Shirai; Junji Utino; Kuniaki Otsuka; Masanobu Takata
Journal:  J Atheroscler Thromb       Date:  2006-04       Impact factor: 4.928

4.  Clinical correlations and prognosis based on serum autoantibodies in patients with systemic sclerosis.

Authors:  V D Steen; D L Powell; T A Medsger
Journal:  Arthritis Rheum       Date:  1988-02

Review 5.  Early intervention in pulmonary arterial hypertension associated with systemic sclerosis: an essential component of disease management.

Authors:  E Hachulla; C P Denton
Journal:  Eur Respir Rev       Date:  2010-12

6.  Right ventricular diastolic abnormalities in systemic sclerosis. Relation to left ventricular involvement and pulmonary hypertension.

Authors:  A Giunta; E Tirri; S Maione; S Cangianiello; A Mele; A De Luca; G Valentini
Journal:  Ann Rheum Dis       Date:  2000-02       Impact factor: 19.103

7.  Decreased nitric oxide in the exhaled air of patients with systemic sclerosis with pulmonary hypertension.

Authors:  S A Kharitonov; J B Cailes; C M Black; R M du Bois; P J Barnes
Journal:  Thorax       Date:  1997-12       Impact factor: 9.139

Review 8.  Clinical manifestations of systemic sclerosis.

Authors:  V D Steen
Journal:  Semin Cutan Med Surg       Date:  1998-03

9.  Pulmonary hypertension in the CREST syndrome variant of systemic sclerosis.

Authors:  A M Stupi; V D Steen; G R Owens; E L Barnes; G P Rodnan; T A Medsger
Journal:  Arthritis Rheum       Date:  1986-04

10.  Serum VEGF levels are related to the presence of pulmonary arterial hypertension in systemic sclerosis.

Authors:  Andriana I Papaioannou; Epaminondas Zakynthinos; Konstantinos Kostikas; Theodoros Kiropoulos; Angela Koutsokera; Athanasios Ziogas; Athanasios Koutroumpas; Lazaros Sakkas; Konstantinos I Gourgoulianis; Zoe D Daniil
Journal:  BMC Pulm Med       Date:  2009-05-09       Impact factor: 3.317

View more
  1 in total

1.  Outcomes of Pulmonary Endarterectomy for Chronic Thromboembolic Pulmonary Hypertension at a Single Center in Taiwan.

Authors:  Yu-Jhou Chen; Chien-Te Ho; Feng-Chun Tsai; Chia-Pin Lin; Lung-An Hsu; Chun-Li Wang; Kuang-Tso Lee; Wan-Jing Ho
Journal:  Acta Cardiol Sin       Date:  2019-03       Impact factor: 2.672

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.